Best Penny Stocks Under 50 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.50 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.50. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Tilray NASDAQ:TLRY$0.49 0.00 (-0.96%) As of 04:00 PM EasternTilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. More about TilrayMarket Capitalization$488.25 millionP/E Ratio-1.62Consensus RatingHoldConsensus Price Target$1.92 (+295.1% Upside)Volume27.48 million sharesAverage Volume29.51 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Sunnova Energy International NYSE:NOVA$0.19 -0.04 (-17.65%) As of 03:59 PM EasternSunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy InternationalMarket Capitalization$23.23 millionP/E Ratio-0.06Consensus RatingHoldConsensus Price Target$4.93 (+2,555.8% Upside)Volume7.41 million sharesAverage Volume11.10 million shares3. GlycoMimetics NASDAQ:GLYC$0.25 +0.02 (+6.48%) As of 04:00 PM EasternGlycoMimetics, Inc, a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. More about GlycoMimeticsMarket Capitalization$16.23 millionP/E Ratio-0.43Consensus RatingHoldVolume363,952 sharesAverage Volume6.72 million sharesToday's Range$0.24▼$0.274. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$12.00 (+6,457.4% Upside)Volume36.66 million sharesAverage Volume8.73 million shares5. EON Resources NYSEAMERICAN:EONR$0.42 0.00 (-0.35%) As of 04:10 PM EasternEON Resources Inc, an independent oil and natural gas company, focuses on the acquisition, development, exploration, and production of oil and natural gas properties in the Permian Basin. More about EON ResourcesConsensus RatingBuyConsensus Price Target$4.50 (+962.3% Upside)Volume260,392 sharesAverage Volume3.77 million sharesToday's Range$0.40▼$0.4250-Day Range$0.00▼$0.006. ReShape Lifesciences NASDAQ:RSLS$0.34 -0.01 (-1.74%) As of 04:00 PM EasternReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. More about ReShape LifesciencesMarket Capitalization$3.82 millionP/E Ratio-0.02Consensus RatingHoldVolume1.28 million sharesAverage Volume3.98 million sharesToday's Range$0.33▼$0.357. Applied Therapeutics NASDAQ:APLT$0.41 +0.02 (+4.23%) As of 04:00 PM EasternApplied Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. More about Applied TherapeuticsMarket Capitalization$57.93 millionP/E Ratio-0.25Consensus RatingModerate BuyConsensus Price Target$6.10 (+1,390.7% Upside)Volume1.15 million sharesAverage Volume3.17 million shares8. bioAffinity Technologies NASDAQ:BIAF$0.47 +0.02 (+4.68%) As of 04:00 PM EasternbioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. More about bioAffinity TechnologiesMarket Capitalization$8.58 millionP/E Ratio-0.57Consensus RatingHoldConsensus Price Target$6.00 (+1,176.6% Upside)Volume60,601 sharesAverage Volume2.46 million shares9. Tenaya Therapeutics NASDAQ:TNYA$0.48 -0.01 (-1.66%) As of 04:00 PM EasternTenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$41.60 millionP/E Ratio-0.33Consensus RatingBuyConsensus Price Target$6.25 (+1,215.8% Upside)Volume1.71 million sharesAverage Volume2.31 million shares10. Zapp Electric Vehicles Group NASDAQ:ZAPP$0.49 -0.03 (-5.82%) As of 03:52 PM EasternZapp Electric Vehicles Group Ltd. engages in the provision of designs, manufactures and sells electric vehicles. It operates through the following geographical segments: Cayman Islands, Europe, and Thailand. More about Zapp Electric Vehicles GroupMarket Capitalization$3.89 millionConsensus RatingStrong BuyConsensus Price Target$3.00 (+512.2% Upside)Volume166,921 sharesAverage Volume2.23 million sharesToday's Range$0.47▼$0.5311. Cardio Diagnostics NASDAQ:CDIO$0.42 -0.03 (-6.76%) As of 04:00 PM EasternCardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. More about Cardio DiagnosticsMarket Capitalization$22.15 millionConsensus RatingBuyConsensus Price Target$2.00 (+370.8% Upside)Volume539,342 sharesAverage Volume2.57 million sharesToday's Range$0.41▼$0.4512. Mersana Therapeutics NASDAQ:MRSN$0.43 +0.06 (+17.19%) As of 04:00 PM EasternMersana Therapeutics, Inc, a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. More about Mersana TherapeuticsMarket Capitalization$53.95 millionP/E Ratio-0.71Consensus RatingBuyConsensus Price Target$4.00 (+824.0% Upside)Volume3.29 million sharesAverage Volume2.50 million shares13. Cognition Therapeutics NASDAQ:CGTX$0.43 +0.01 (+2.33%) As of 04:00 PM EasternCognition Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. More about Cognition TherapeuticsMarket Capitalization$26.46 millionP/E Ratio-0.44Consensus RatingBuyConsensus Price Target$7.13 (+1,569.0% Upside)Volume240,231 sharesAverage Volume2.53 million shares14. Genprex NASDAQ:GNPX$0.29 +0.01 (+3.57%) As of 04:00 PM EasternGenprex, Inc, a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. More about GenprexMarket Capitalization$7.00 millionConsensus RatingBuyConsensus Price Target$10.00 (+3,348.3% Upside)Volume1.87 million sharesAverage Volume3.70 million sharesToday's Range$0.26▼$0.2915. Vaxart NASDAQ:VXRT$0.44 +0.01 (+3.39%) As of 04:00 PM EasternVaxart, Inc, a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. More about VaxartMarket Capitalization$100.32 millionP/E Ratio-1.07Consensus RatingBuyConsensus Price Target$3.00 (+582.4% Upside)Volume1.68 million sharesAverage Volume2.41 million shares16. Canoo NASDAQ:GOEV$0.34 -0.07 (-15.95%) Closing price 01/28/2025Extended Trading$0.34 0.00 (0.00%) As of 01/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canoo Inc, a mobility technology company, designs, develops, markets, and manufactures electric vehicles for consumer, commercial fleet, government, and military customers in the United States. More about CanooMarket Capitalization$1.67 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$42.63 (+12,291.0% Upside)Volume6.24 million sharesAverage Volume2.92 million shares17. Aethlon Medical NASDAQ:AEMD$0.38 -0.03 (-6.41%) As of 04:00 PM EasternAethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. More about Aethlon MedicalMarket Capitalization$6.12 millionP/E Ratio-0.24Consensus RatingBuyConsensus Price Target$7.00 (+1,737.3% Upside)Volume150,580 sharesAverage Volume2.48 million shares18. ImmunoPrecise Antibodies NASDAQ:IPA$0.44 0.00 (-1.02%) As of 04:00 PM EasternImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. More about ImmunoPrecise AntibodiesMarket Capitalization$13.61 millionP/E Ratio-0.56Consensus RatingBuyConsensus Price Target$4.00 (+813.2% Upside)Volume106,432 sharesAverage Volume2.10 million shares19. TransCode Therapeutics NASDAQ:RNAZ$0.41 -0.03 (-5.88%) As of 04:00 PM EasternTransCode Therapeutics, Inc, a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. More about TransCode TherapeuticsMarket Capitalization$9.49 millionConsensus RatingBuyConsensus Price Target$10.00 (+2,359.4% Upside)Volume1.69 million sharesAverage Volume2.07 million sharesToday's Range$0.39▼$0.4320. LeddarTech NASDAQ:LDTC$0.39 -0.03 (-7.12%) As of 04:00 PM EasternLeddarTech Holdings Inc provides AI-based fusion and perception software solutions for advanced driver assistance solutions and autonomous driving applications in Canada. More about LeddarTechMarket Capitalization$11.22 millionP/E Ratio-0.12Consensus RatingModerate BuyConsensus Price Target$3.00 (+669.0% Upside)Volume109,380 sharesAverage Volume2.09 million shares21. Brand Engagement Network NASDAQ:BNAI$0.36 0.00 (-1.10%) As of 04:00 PM EasternBrand Engagement Network, Inc provides conversational AI assistants. The company offers security-focused, multimodal communication, and human-like assistants. More about Brand Engagement NetworkMarket Capitalization$15.18 millionConsensus RatingBuyConsensus Price Target$6.00 (+1,571.3% Upside)Volume102,699 sharesAverage Volume2.22 million sharesToday's Range$0.35▼$0.3722. FibroGen NASDAQ:FGEN$0.34 +0.01 (+3.21%) As of 04:00 PM EasternFibroGen, Inc, a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. More about FibroGenMarket Capitalization$34.15 millionP/E Ratio-0.27Consensus RatingModerate BuyConsensus Price Target$10.00 (+2,858.6% Upside)Volume434,885 sharesAverage Volume2.24 million shares23. Asensus Surgical NYSEAMERICAN:ASXC$0.35 0.00 (0.00%) As of 08/22/2024Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. More about Asensus SurgicalMarket Capitalization$94.74 millionP/E Ratio-1.12Consensus RatingHoldConsensus Price Target$0.35 (+0.6% Upside)Average Volume2.03 million sharesToday's Range$0.35▼$0.3524. Lineage Cell Therapeutics NYSEAMERICAN:LCTX$0.50 +0.03 (+5.94%) As of 04:10 PM EasternLineage Cell Therapeutics, Inc, a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally. More about Lineage Cell TherapeuticsMarket Capitalization$109.99 millionP/E Ratio-4.16Consensus RatingBuyConsensus Price Target$4.20 (+741.7% Upside)Volume1.49 million sharesAverage Volume1.33 million shares25. 23andMe NASDAQ:ME$0.50 -0.27 (-35.32%) Closing price 03/28/2025Extended Trading$0.50 0.00 (0.00%) As of 03/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. More about 23andMeMarket Capitalization$13.36 millionP/E Ratio-0.03Consensus RatingSellVolume29.28 million sharesAverage Volume1.23 million sharesToday's Range$0.60▼$1.10 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
